NO20033144D0 - Modulore transfeksjonssystemer - Google Patents

Modulore transfeksjonssystemer

Info

Publication number
NO20033144D0
NO20033144D0 NO20033144A NO20033144A NO20033144D0 NO 20033144 D0 NO20033144 D0 NO 20033144D0 NO 20033144 A NO20033144 A NO 20033144A NO 20033144 A NO20033144 A NO 20033144A NO 20033144 D0 NO20033144 D0 NO 20033144D0
Authority
NO
Norway
Prior art keywords
transfection
protein
modified
present
relates
Prior art date
Application number
NO20033144A
Other languages
English (en)
Other versions
NO20033144L (no
Inventor
Hanns-Martin Schmidt
Ludger Altrogge
Dietmar Lenz
Gudula Riemen
Helmut Brosterhus
Elke Lorbach
Juliana Helfrich
Katharina Hein
Marion Gremse
Tatjana Males
Rainer Christine
Gregor Siebenkotten
Bodo Ortmann
Tamara Turbanski
Andrea Klaes
Original Assignee
Amaxa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amaxa Gmbh filed Critical Amaxa Gmbh
Publication of NO20033144D0 publication Critical patent/NO20033144D0/no
Publication of NO20033144L publication Critical patent/NO20033144L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Fluid-Driven Valves (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Reciprocating, Oscillating Or Vibrating Motors (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20033144A 2001-01-10 2003-07-09 Modul¶re transfeksjonssystemer NO20033144L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10100996 2001-01-10
PCT/DE2002/000060 WO2002055721A2 (de) 2001-01-10 2002-01-10 Modulare transfektionssysteme auf der basis von nukleoproteinfilamenten

Publications (2)

Publication Number Publication Date
NO20033144D0 true NO20033144D0 (no) 2003-07-09
NO20033144L NO20033144L (no) 2003-09-01

Family

ID=7670249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033144A NO20033144L (no) 2001-01-10 2003-07-09 Modul¶re transfeksjonssystemer

Country Status (12)

Country Link
US (2) US7320859B2 (no)
EP (1) EP1427837B1 (no)
JP (2) JP4551058B2 (no)
KR (1) KR100912741B1 (no)
CN (1) CN100510087C (no)
AT (1) ATE530659T1 (no)
AU (1) AU2002238376B2 (no)
CA (1) CA2434402A1 (no)
DE (1) DE10290072D2 (no)
IL (1) IL156780A0 (no)
NO (1) NO20033144L (no)
WO (1) WO2002055721A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
ES2411962T3 (es) 2003-10-24 2013-07-09 Gencia Corporation Métodos y composiciones para suministrar polinucleótidos
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US20110045058A1 (en) * 2007-11-20 2011-02-24 Beth Israel Deaconess Medical Center Transfection reagent
KR200453773Y1 (ko) * 2008-07-07 2011-05-27 류선영 다용도 일회용 냅킨
EP2208778A1 (de) 2009-01-20 2010-07-21 Lonza Cologne AG Verfahren und Vorrichtung zur elektrischen Behandlung von Reaktionsräumen
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
WO2012098260A1 (en) 2011-01-21 2012-07-26 Axiogenesis Ag A non-viral system for the generation of induced pluripotent stem (ips) cells
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
WO2018229521A1 (en) 2016-06-16 2018-12-20 Oslo Universitetssykehus Hf Improved gene editing
WO2019075373A1 (en) * 2017-10-12 2019-04-18 Mayo Foundation For Medical Education And Research METHODS AND COMPOSITIONS FOR GENE EDITION
KR102470059B1 (ko) 2018-05-18 2022-11-22 에프. 호프만-라 로슈 아게 큰 핵산의 표적화된 세포내 전달

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
US5763240A (en) * 1992-04-24 1998-06-09 Sri International In vivo homologous sequence targeting in eukaryotic cells
US5468629A (en) * 1993-04-13 1995-11-21 Calhoun; Cornelia Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein
US5807746A (en) * 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
US5948653A (en) * 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
CN1262668C (zh) 1999-01-08 2006-07-05 阿马克萨有限公司 转移核酸通过核被膜的细胞转运系统的用途
EP1165819A2 (en) * 1999-03-31 2002-01-02 Invitrogen Corporation Delivery of functional protein sequences by translocating polypeptides
US6977295B2 (en) 1999-04-21 2005-12-20 Invitrogen Corporation Locked nucleic acid hybrids and methods of use
DE19925052B4 (de) 1999-06-01 2012-01-12 Alexander Cherkasky Proteinkomplexe für den zielgerichteten Transport von (Poly)Peptide und Nukleinsäuren und sequenzspezifische Integration von DNA-Vektoren

Also Published As

Publication number Publication date
WO2002055721A3 (de) 2004-04-15
JP4551058B2 (ja) 2010-09-22
ATE530659T1 (de) 2011-11-15
DE10290072D2 (de) 2003-12-18
KR20030074702A (ko) 2003-09-19
US20080220527A1 (en) 2008-09-11
JP2005505233A (ja) 2005-02-24
EP1427837A2 (de) 2004-06-16
IL156780A0 (en) 2004-02-08
AU2002238376B2 (en) 2007-05-10
WO2002055721B1 (de) 2004-05-27
WO2002055721A2 (de) 2002-07-18
EP1427837B1 (de) 2011-10-26
US20040137622A1 (en) 2004-07-15
CN100510087C (zh) 2009-07-08
JP4697982B2 (ja) 2011-06-08
JP2008200041A (ja) 2008-09-04
US7320859B2 (en) 2008-01-22
KR100912741B1 (ko) 2009-08-18
CN1529759A (zh) 2004-09-15
NO20033144L (no) 2003-09-01
US7999073B2 (en) 2011-08-16
CA2434402A1 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
DE10290072D2 (de) Modulare Transfektionssysteme
IL158474A0 (en) Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
CN110291198A (zh) 经修饰的指导rna
ATE443720T1 (de) Fc-interferon-beta fusionsproteine
ATE353013T1 (de) Trizyklische pyrazolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor mittel
BRPI0411112A (pt) proteìna de fusão heteróloga, polinucleotìdeo, vetor, célula hospedeira, processo para produzir uma proteìna de fusão heteróloga, método para tratar um paciente, e, uso de proteìna de fusão heteróloga
MXPA03010402A (es) Derivados de 4-amino-5-fenil-7-ciclobutil-pirrolo (2,3-d) pirimidina.
RU2004108061A (ru) Способ лечения онкологических заболеваний
ATE264671T1 (de) Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
DK1487416T3 (da) Lægemiddelmikropartikler
BR0316157A (pt) Derivados de 4-amino-5-fenil-7-ciclohexil-pirrolo[2,3-d]pirimidina
DE602005009978D1 (de) Verfahren zur herstellung von zwei- und dreidimensionalen polymergerüsten
DE60203692D1 (de) Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen
EP1362600A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LURE AND METHOD OF USE THEREOF
DE60215313D1 (de) Indolderivate und deren verwendung als gnrh antagonisten
ATE478688T1 (de) Verbindungen für den transfer von oligonukleotiden
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
WO2000043510A3 (en) Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use
DE60035504D1 (de) Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung
DE60115622D1 (de) Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen
ATE278011T1 (de) Human dnase ii
ATE265234T1 (de) Pharmazeutische zusammensetzung von hydrophob modifizierten hedgehog-proteinen und deren verwendung
BR0317292A (pt) Derivados de amida de ácido antranìlico e seu uso farmacêutico
Morrison mRNA Vaccines and their impact on medicine.
ATE484516T1 (de) 3.beta.,28-diacetoxy-18-oxo-19,20,21,29,30- pentanorlupan-22-säure solvate, verfahren zu ihrer herstellung und pharmazeutische präparate daraus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application